| Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses C Drechsler, MJ Bolland, I Reid, J Willeit, G Schett, P Santer, R Sofat, ... The Lancet Diabetes & Endocrinology, 2021 | 156* | 2021 |
| Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses L Sun, L Pennells, S Kaptoge, CP Nelson, SC Ritchie, G Abraham, ... PLoS medicine 18 (1), e1003498, 2021 | 142 | 2021 |
| Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study N Tangri, T Moriyama, MP Schneider, JB Virgitti, L De Nicola, M Arnold, ... BMJ Open 13 (5), e067386, 2023 | 71 | 2023 |
| Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis P Bhuyan, J Medin, HG da Silva, M Yadavalli, NK Shankar, H Mullerova, ... The Lancet, 2021 | 67 | 2021 |
| Reproducibility of dietary intakes of macronutrients, specific food groups, and dietary patterns in 211 050 adults in the UK Biobank study JL Carter, S Lewington, C Piernas, K Bradbury, TJ Key, SA Jebb, ... Journal of nutritional science 8, 2019 | 66 | 2019 |
| Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases SC Ritchie, SA Lambert, M Arnold, SM Teo, S Lim, P Scepanovic, ... Nature Metabolism, 1-8, 2021 | 64 | 2021 |
| Assessment of the Role of Carotid Atherosclerosis in the Association Between Major Cardiovascular Risk Factors and Ischemic Stroke Subtypes S Parish, M Arnold, R Clarke, H Du, E Wan, O Kurmi, Y Chen, Y Guo, ... JAMA Network Open 2 (5), e194873-e194873, 2019 | 57 | 2019 |
| Burden of carotid artery atherosclerosis in Chinese adults: Implications for future risk of cardiovascular diseases R Clarke, H Du, O Kurmi, S Parish, M Yang, M Arnold, Y Guo, Z Bian, ... European Journal of Preventive Cardiology 24 (6), 647-656, 2017 | 54 | 2017 |
| Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK Biobank NE Allen, M Arnold, S Parish, M Hill, S Sheard, H Callen, D Fry, S Moffat, ... Wellcome Open Research 5, 2020 | 46 | 2020 |
| A biomarker-based biological age in UK Biobank: composition and prediction of mortality and hospital admissions MS Chan, M Arnold, A Offer, I Hammami, M Mafham, J Armitage, R Perera, ... The Journals of Gerontology: Series A, 2021 | 44 | 2021 |
| Prediction of Cardiovascular Disease Risk Accounting for Future Initiation of Statin Treatment Z Xu, M Arnold, D Stevens, S Kaptoge, L Pennells, MJ Sweeting, J Barrett, ... American Journal of Epidemiology, 2021 | 36 | 2021 |
| Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia E Kanda, A Rastogi, T Murohara, E Lesén, A Agiro, M Arnold, G Chen, ... BMC nephrology 24 (1), 18, 2023 | 34 | 2023 |
| Mild-to-moderate kidney dysfunction and cardiovascular disease: observational and Mendelian randomisation analyses L Gaziano, L Sun, M Arnold, S Bell, K Cho, SK Kaptoge, RJ Song, ... Circulation, 2022 | 34 | 2022 |
| Methods and rationale of the DISCOVER CKD global observational study R Pecoits-Filho, G James, JJ Carrero, E Wittbrodt, S Fishbane, AA Sultan, ... Clinical Kidney Journal, 2021 | 26 | 2021 |
| Low Adherence to KDIGO 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility G James, JJG Sanchez, JJ Carrero, S Kumar, R Pecoits-Filho, ... Kidney International Reports, 2022 | 21* | 2022 |
| Genetic, lifestyle, and health-related characteristics of adults without celiac disease who follow a gluten-free diet: a population-based study of 124,447 participants TJ Littlejohns, AY Chong, NE Allen, M Arnold, KE Bradbury, AJ Mentzer, ... The American Journal of Clinical Nutrition, 2020 | 19 | 2020 |
| Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort C Pollock, G James, JJ Garcia Sanchez, M Arnold, JJ Carrero, CSP Lam, ... Advances in Therapy, 1-14, 2022 | 17 | 2022 |
| Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEAL-CKD study P Kushner, E Peach, E Wittbrodt, S Barone, H Chen, JJG Sanchez, ... Clinical Kidney Journal, 2021 | 16 | 2021 |
| Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical … A Offer, M Arnold, R Clarke, D Bennett, L Bowman, R Bulbulia, R Haynes, ... JAMA network open 2 (3), e190223-e190223, 2019 | 15 | 2019 |
| Healthcare resource utilisation and related costs of patients with CKD from the United Kingdom: a report from the DISCOVER CKD retrospective cohort C Pollock, G James, JJG Sanchez, JJ Carrero, M Arnold, CSP Lam, ... Clinical Kidney Journal, 2022 | 14 | 2022 |
